查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363097

滥用药物检测服务的市场规模、份额和趋势分析报告：按药物类型、地区和细分市场分類的趋势，2023-2030 年

Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD ), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

滥用药物测试服务市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球滥用药物检测服务市场规模将达85.4亿美元，2023年至2030年年复合成长率为3.91%。

发达的实验室网路的存在和成瘾的盛行是市场成长的主要促进因素。此外，社区中各种药物使用的增加趋势以及非法药物和酒精检测检测的重要性预计将推动需求。因此，世界各地持续提供的测试正在推动成长。

此外，越来越多的精神疾病患者和因吸毒而住院的患者也推动了需求。例如，2023 年 1 月，SAMHSA 发布了 2021 年全国药物使用和健康调查，其中提供了有关精神疾病和药物使用程度的详细资讯。研究发现，12岁以上人口中有16.5%（4,630万人）患有物质使用障碍，2,950万人患有酒精使用障碍，2,400万人患有药物使用障碍。

此外，公众意识的提高以及青少年和成年人对成瘾和非法药物使用治疗的未满足的需求预计将推动对滥用药物检测服务行业的需求。例如，2020年8月，Averhealth宣布收购亚利桑那州治疗评估筛检中心的药物检测服务。因此，越来越多的玩家关注新兴国家的成瘾负担最小化正在推动市场收益。这项要素正在推动公司针对滥用案件开发创新且有效的服务。

同样，COVID-19大流行也对市场产生了一定影响。在大流行期间，青少年和成年人对大麻/大麻和阿片类药物成瘾的增加对检测服务产生了持续的需求。根据联合国毒品犯罪防制署（UNODC）统计，2020年全球约有2.75亿人使用毒品，而根据2021年世界毒品报告，超过3,600万人患有吸毒障碍。这些要素正在增加对疫情后服务的需求。

此外，主要参与企业正在采取协议、併购、合作伙伴关係和产品发布等策略，以扩大其全球足迹和产品系列。例如，2022年12月，欧米茄实验室在加拿大推出了尿液滥用药物检测服务。此外，从 2023 年 1 月开始，我们计划提供尿液检查来补充分子检测。扩大毒理学测试服务将为消费者提供加拿大有限选择的替代方案。

滥用药物测试服务市场报告亮点

  • 大麻/大麻领域市场在 2022 年占据市场最大的收益占有率，由于大麻/大麻成瘾的盛行、医疗筛检和就业测试的需求，预计在预测期内将以最快的成长率成长。
  • 2022年，北美将拥有最大的市场占有率。成熟市场参与者的存在、对各种成瘾治疗的需求、消费的增长以及青少年对大麻/大麻的成瘾正在推动该地区的成长。
  • 领先的滥用药物检测服务主要企业不断专注于产品发布和地理扩张，以维持其地位。

目录

第1章滥用药物检测服务市场：调查方法与范围

第2章滥用药物检测服务市场：执行摘要

  • 市场概述
  • 药品类型简介
  • 竞争形势概览

第3章滥用药物测试服务市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场动态
  • 市场促进因素分析
    • 药物滥用的盛行及其治疗需求的不断增长
    • 政府配合措施监测药物滥用
    • 严格的法律要求进行酒精和药物测试
  • 市场抑制因素分析
    • 在一些国家，药物测试被认为侵犯隐私权
  • 波特五力分析
  • PESTLE分析

第4章滥用药物检测服务市场：按药物类型估计和趋势分析

  • 滥用药物测试服务市场：药物类型变异分析
  • 酒精
  • 大麻/大麻
  • 古柯碱
  • 阿片类药物
  • 安非他明和甲基安非他明
  • LSD
  • 其他的

第5章滥用药物检测服务市场：按地区分類的业务分析

  • 区域市场简介
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第6章竞争形势

  • 公司分类
  • 策略规划
    • 新推出
    • 合伙
    • 获得
    • 合作
  • 2022年主要企业市场占有率分析
  • 企业热力图分析
  • 公司简介
    • QUEST DIAGNOSTICS
    • ABBOTT
    • CLINICAL REFERENCE LABORATORY（CRL）, INC.
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • CORDANT HEALTH SOLUTIONS
    • LEGACY MEDICAL SERVICES
    • DRUGSCAN
    • OMEGA LABORATORIES, INC.
    • PSYCHEMEDICS CORPORATION
    • MILLENNIUM HEALTH, LLC
    • MAYO CLINIC LABORATORIES
    • PRECISION DIAGNOSTICS
    • AMERICAN SUBSTANCE ABUSE PROFESSIONALS（ASAP）, INC.
    • UNITED STATES DRUG TESTING LABORATORIES（USDTL）, INC.
    • LGC GROUP
Product Code: GVR-2-68038-254-9

Drug Of Abuse Testing Services Market Growth & Trends:

The global drug of abuse testing services market size is expected to reach USD 8.54 billion by 2030, expanding at a CAGR of 3.91% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The presence of a developed laboratory network and the prevalence of addiction are key drivers for market growth. Furthermore, the increasing trend of different drug use in the community and the importance of testing for the detection of illicit drugs and alcohol is expected to drive the demand. Thereby, continued test offering across the globe has fueled the growth.

Additionally, rising psychiatric disorders patients and hospitalizations due to the consumption of the drugs have boosted the demand. For instance, January 2023, National Survey on Drug Use and Health Results Detailing Mental Illness & Substance Use Levels (2021) was announced by SAMHSA. The survey mentioned that 16.5% of the aged 12 or older population (or 46.3 million) people had a substance use disorder wherein 29.5 million people were classified to have alcohol use disorder & 24 million people had drug use disorder.

In addition, the growing awareness among the population and the unmet need for treatment of addiction and illicit medication use among youth and adults is projected to boost the demand for the drug of abuse testing services industry. For instance, in August 2020, Averhealth announced the acquisition of the drug testing services of the Treatment Assessment Screening Center in Arizona. Therefore, increasing the focus of players to minimize the burden of addiction in emerging countries propels the market revenue. This factor has led companies to develop innovative and effective services for abuse cases.

Likewise, the COVID-19 pandemic has moderately impacted the market. During the pandemic, a constant demand for detection services was attributable to the increased addiction to Cannabis/Marijuana and opioids among the youth and adult population. According to United Nations Office on Drugs and Crime (UNODC), in 2020, around 275 million people used drugs worldwide, while according to the 2021 World Drug Report, over 36 million population suffered from drug use disorders. This factor has led to rising requirements for services post-pandemic.

Furthermore, the key participants are engaged in strategies such as agreements, mergers & acquisitions, partnerships, and launches, among others, to expand their global footprints and product portfolio. For instance, in December 2022, Urine Drugs of Abuse testing services was launched by Omega Laboratories in Canada. Adding to that from January 2023, the laboratory will offer urine testing to complement its molecular testing. The expansion of toxicology services will offer consumers an alternative to limited options available in Canada.

Drug Of Abuse Testing Services Market Report Highlights:

  • Cannabis/Marijuana segment held the largest revenue share of the market in 2022 and is anticipated to grow at the fastest growth rate over the forecast period owing to the prevalence of cannabis/marijuana addiction, demand for medical screening, and employment testing drives the growth
  • North America held the largest share of the market in 2022. The presence of well-established market players, demand for various addiction treatments, growing consumption, and addiction to cannabis/marijuana among youth drive regional growth
  • Key players operating in the drug of abuse testing services constantly focus on product launches and geographical expansion to maintain their presence

Table of Contents

Chapter 1. Drug of Abuse Testing Services Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Drug Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Drug of Abuse Testing Services Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Type Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Drug of Abuse Testing Services Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. High prevalence of substance abuse & growing demand for its treatment
    • 3.4.2. Increase in government initiatives to monitor substance abuse
    • 3.4.3. Stringent law mandating alcohol and drug testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. Drug testing is considered a violation of privacy rights in some countries
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. Drug of Abuse Testing Services Market: Drug Type Estimates & Trend Analysis

  • 4.1. Drug of Abuse Testing Services Market: Drug Type Movement Analysis
  • 4.2. Alcohol
    • 4.2.1. Alcohol Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Cannabis/Marijuana
    • 4.3.1. Cannabis/Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cocaine
    • 4.4.1. Cocaine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Opioids
    • 4.5.1. Opioids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Amphetamine & Methamphetamine
    • 4.6.1. Amphetamine & Methamphetamine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. LSD
    • 4.7.1. LSD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug of Abuse Testing Services Market: Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Drug of Abuse Testing Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Reimbursement Scenario
      • 5.2.2.5. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Reimbursement Scenario
      • 5.2.3.5. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement Scenario
      • 5.3.2.5. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement Scenario
      • 5.3.3.5. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement Scenario
      • 5.3.4.5. Competitive Scenario
    • 5.3.5. Spain
      • 5.3.5.1. Spain Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Reimbursement Scenario
      • 5.3.5.5. Competitive Scenario
    • 5.3.6. Italy
      • 5.3.6.1. Italy Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Reimbursement Scenario
      • 5.3.6.5. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement Scenario
      • 5.3.7.5. Competitive Scenario
    • 5.3.8. Norway
      • 5.3.8.1. Norway Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement Scenario
      • 5.3.8.5. Competitive Scenario
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement Scenario
      • 5.3.9.5. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia-Pacific Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement Scenario
      • 5.4.2.5. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement Scenario
      • 5.4.3.5. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement Scenario
      • 5.4.4.5. Competitive Scenario
    • 5.4.5. Australia
      • 5.4.5.1. Australia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement Scenario
      • 5.4.5.5. Competitive Scenario
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement Scenario
      • 5.4.6.5. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement Scenario
      • 5.4.7.5. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.2.2. Key Country Dynamics
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement Scenario
      • 5.5.2.5. Competitive Scenario
    • 5.5.3. Mexico
      • 5.5.3.1. Mexico Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.3.2. Key Country Dynamics
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement Scenario
      • 5.5.3.5. Competitive Scenario
    • 5.5.4. Argentina
      • 5.5.4.1. Argentina Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.5.4.2. Key Country Dynamics
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. Reimbursement Scenario
      • 5.5.4.5. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement Scenario
      • 5.6.2.5. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement Scenario
      • 5.6.3.5. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement Scenario
      • 5.6.4.5. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Drug of Abuse Testing Services Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement Scenario
      • 5.6.5.5. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. New Launch
    • 6.2.2. Partnerships
    • 6.2.3. Acquisition
    • 6.2.4. Collaboration
  • 6.3. Key Company Market Share Analysis, 2022
  • 6.4. Company Heat Map Analysis
  • 6.5. Company Profiles
    • 6.5.1. QUEST DIAGNOSTICS
      • 6.5.1.1. Company Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. ABBOTT
      • 6.5.2.1. Company Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. CLINICAL REFERENCE LABORATORY (CRL), INC.
      • 6.5.3.1. Company Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 6.5.4.1. Company Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. CORDANT HEALTH SOLUTIONS
      • 6.5.5.1. Company Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. LEGACY MEDICAL SERVICES
      • 6.5.6.1. Company Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Product Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. DRUGSCAN
      • 6.5.7.1. Company Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. OMEGA LABORATORIES, INC.
      • 6.5.8.1. Company Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. PSYCHEMEDICS CORPORATION
      • 6.5.9.1. Company Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. MILLENNIUM HEALTH, LLC
      • 6.5.10.1. Company Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic Initiatives
    • 6.5.11. MAYO CLINIC LABORATORIES
      • 6.5.11.1. Company Overview
      • 6.5.11.2. Financial Performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Strategic Initiatives
    • 6.5.12. PRECISION DIAGNOSTICS
      • 6.5.12.1. Company Overview
      • 6.5.12.2. Financial Performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Strategic Initiatives
    • 6.5.13. AMERICAN SUBSTANCE ABUSE PROFESSIONALS (ASAP), INC.
      • 6.5.13.1. Company Overview
      • 6.5.13.2. Financial Performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Strategic Initiatives
    • 6.5.14. UNITED STATES DRUG TESTING LABORATORIES (USDTL), INC.
      • 6.5.14.1. Company Overview
      • 6.5.14.2. Financial Performance
      • 6.5.14.3. Product Benchmarking
      • 6.5.14.4. Strategic Initiatives
    • 6.5.15. LGC GROUP
      • 6.5.15.1. Company Overview
      • 6.5.15.2. Financial Performance
      • 6.5.15.3. Product Benchmarking
      • 6.5.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Drug of Abuse Testing Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 North America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 7 Canada Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 8 Europe Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 Europe Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 10 Germany Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 11 UK Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 12 France Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Spain Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 14 Italy Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Denmark Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 16 Norway Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 17 Sweden Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 20 Japan Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 21 China Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 22 India Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 23 Australia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 24 South Korea Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 25 Thailand Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Latin America Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Latin America Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 28 Brazil Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 29 Mexico Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 30 Argentina Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Drug of Abuse Testing Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 33 Saudi Arabia Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 35 UAE Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Drug of Abuse Testing Services Market, By Drug Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global drug of abuse testing services market - Key market driver analysis
  • Fig. 7 Global drug of abuse testing services market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global drug of abuse testing services market - Porter's analysis
  • Fig. 10 Global drug of abuse testing services market - PESTEL analysis
  • Fig. 11 Global drug of abuse testing services market drug type outlook key takeaways
  • Fig. 12 Global drug of abuse testing services market: Drug type movement analysis
  • Fig. 13 Alcohol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Cannabis/Marijuana market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Cocaine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Opioids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Amphetamine & Methamphetamine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 LSD market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Regional marketplace: Key takeaways
  • Fig. 21 Global drug of abuse testing services market: Regional movement analysis
  • Fig. 22 North America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 24 Canada drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 25 Europe drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 26 Germany drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 27 UK drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 28 France drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 29 Spain drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 30 Italy drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 31 Denmark drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 32 Norway drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 36 China drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 37 India drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 40 Thailand drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 41 Latin America drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 42 Brazil drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 44 Argentina drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 45 MEA drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 46 South Africa drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 48 UAE drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 49 Kuwait drug of abuse testing services market, 2018 - 2030 (USD Million)
  • Fig. 50 Strategy framework